CD31 or Factor VIII-related antigen (F VIII RAg) immunohistochemistry (IHC), is widely used in experimental studies quantifing tumor neovascularization in immunocompromised animal …

May 25, 2019 · Background: The aim of this study was to evaluate microvessel density (MVD) by expression of CD31 and CLEC14A in core biopsies from previously untreated patients with …

In the paper, we explored the expression condition of tumor neovascular EC markers CD31, CD34, and CD105 in GGNs by the IHC method, analyzing the difference of MVD in GGNs with …

May 22, 2017 · Microvessel density (MVD) quantified based on CD31-positive endothelial cells in tumor samples assayed by IHC is often used as a surrogate for tumoral angiogenic activity . …

Sep 6, 2019 · In all types of tumor, MVD was higher in CD31+ than CD34+ staining marks, but differences were only statistically significant in ccRCC (p<0.05) and pRCC (p<0.01). CD31+ …

Sep 5, 2020 · Tumor angiogenesis measured by CD31 MVD is an independent prognostic factor for both PFS and OS in high-risk, early-stage cervical cancer. We hypothesize that this finding …

Nov 1, 2017 · The potential predictive value of MVD (CD31) and tumor VEGF-A is consistent with a mechanism of action driven by VEGF-A signaling blockade.

Jul 15, 2012 · The degree of MVD in tumor is currently widely assessed by CD31 protein expression. This protein is a marker that can selectively detect glycoprotein of 130 kDa in …

The aim of this study was to evaluate microvessel density (MVD) by expression of CD31 and CLEC14A in core biopsies from previously untreated patients with locally advanced breast …

Sep 1, 2010 · Increased CD31+ MVD correlated positively with the number of tumour infiltrating MCs and CD34+ vessels, and negatively with the outcome. Overall survival and progression …